financetom
Business
financetom
/
Business
/
Summit Therapeutics Q2 Adjusted Loss Widens
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Summit Therapeutics Q2 Adjusted Loss Widens
Aug 11, 2025 2:50 PM

05:28 PM EDT, 08/11/2025 (MT Newswires) -- Summit Therapeutics ( SMMT ) reported Q2 adjusted net loss late Monday of $0.12 per diluted share, widening from $0.07 a year earlier.

The company did not report any revenue for the quarter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved